Data outliers were eliminated by ROUT method with a Q value of 1%. Student's unpaired t -test in GraphPad Prism software was applied and a p-value of 0.05 or lower was considered significant. Data is reported as mRNA fold change compared to control.
Corrigendum to "Inhibition of Fgf signaling in short bowel syndrome increases weight loss and epithelial proliferation." [ We recently reviewed our manuscript and identified two errors: in Fig 2 Panel A, this should have reported the PCR data for erm to confirm the heatshock treatment resulted in decreasing downstream effectors of Fgf signaling. Additionally, the fgfr1 primers were not for qRT-PCR as reported. Expression of Fgfr1 downstream target, erm was examined by qRT-PCR instead. This does not change the fact that the heatshock model was successful or change the conclusions of the paper, but we would like to correct the record.
Methods

Reverse transcription quantitative polymerase chain reaction (RT-qPCR) for erm and fgfr1
Proximal HS SBS and NHS SBS intestinal samples were stored in RNA later. Total RNA was extracted and precipitated with the RNeasy Mini Kit Qiagen (#74104 Hilden, Germany) and dissolved in RNAse free water. Characterization of hsp70:dn-fgfr1 fish was described in. 1 DOI of original article: 10.1016/j.surg.2016.08.044
